Products

First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

exilby

Dr. Clemens Fischer

We believe that research and development are the driving forces behind groundbreaking medical innovation. In order to improve the lives of chronic pain patients worldwide, we invest tens of millions of Euros annually into R&D.

Our efforts are led by a dedicated team of highly experienced professionals who design and oversee our clinical trials, working in close collaboration with an international network of several hundred research and trial centers across Europe and the United States.

First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

Our Testimonials

VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

Best Articles

The villagers are out there with a vengeance to get that Frankenstein, wielding torches and pitchforks.